EcoDrugPlus

Growth Hormone Secretagogue Receptor

Ensembl ID : ENSPEMG00000012672
Gene Symbol: GHSR
3 Cross references
212 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 1

Ensembl ID : ENSPEMG00000015074
Gene Symbol: GUCY1A1
3 Cross references
202 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 2

Ensembl ID : ENSPEMG00000021986
Gene Symbol: GUCY1A2
3 Cross references
201 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Beta 1

Ensembl ID : ENSPEMG00000006854
Gene Symbol: GUCY1B1
3 Cross references
209 Possible Orthologues:

Hemopoietic Cell Kinase

Ensembl ID : ENSPEMG00000021927
Gene Symbol: HCK
1 Cross references
205 Possible Orthologues:

Histamine Receptor H1

Ensembl ID : ENSPEMG00000028414
Gene Symbol: HRH1
1 Cross references
186 Possible Orthologues:

Histamine Receptor H2

Ensembl ID : ENSPEMG00000005710
Gene Symbol: HRH2
3 Cross references
249 Possible Orthologues:

Histamine Receptor H3

Ensembl ID : ENSPEMG00000008738
Gene Symbol: HRH3
1 Cross references
117 Possible Orthologues:

Histamine Receptor H4

Ensembl ID : ENSPEMG00000014230
Gene Symbol: HRH4
3 Cross references
105 Possible Orthologues:

Histone Deacetylase 1

Ensembl ID : ENSPEMG00000023227
Gene Symbol: HDAC1
3 Cross references
275 Possible Orthologues:

Histone Deacetylase 10

Ensembl ID : ENSPEMG00000021370
Gene Symbol: HDAC10
1 Cross references
181 Possible Orthologues:

Histone Deacetylase 11

Ensembl ID : ENSPEMG00000012425
Gene Symbol: HDAC11
3 Cross references
197 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).